You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Radiomics models to predict axillary lymph node metastasis in breast cancer and analysis of the biological significance of radiomic features
- 2. Risk factors for adverse reactions caused by abemaciclib in breast cancer therapy
- 3. Efficacy and safety of Sacituzumab govitecan in solid tumors: a systematic review and meta-analysis
- 4. Millions Stand to Lose Health Coverage Under Proposed Medicaid Cuts, Study Says
- 5. Scientists find new way to predict how bowel cancer drugs will stop working—paving way for smarter treatments
- 6. Breast cancer patients' microbiome may hold key to avoiding damaging heart side-effects of cancer therapies
- 7. Cancer immunotherapy nursing care from 2004 to 2023: a bibliometric analysis
- 8. Thousands of blood cancer patients could benefit from new drug combination
- 9. Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis
- 10. Foresee Pharmaceuticals announces reaching a significant milestone, of complete enrollment of its Phase 3 Casppian trial for patients with Central Precocious Puberty (CPP)
Last updated at 7:41 GMT
Hot News Makers
Health/Pharma Companies
- 9529.68
- 6114.16
- 5368.86
- 2863.39
- 2834.60
- 2202.61
- 1735.64
- 1275.69
- 1115.61
- 1010.61
Drugs, Treatments, Trials
- 590.70
- 354.42
- 138.58
- 92.39
- 67.21
Last updated at 7:10 GMT
